Category
Bortezomib
CAS Number
NA
Molecular Formula
C57H69B3N12O9
Molecular Weight
1098.7g/mol
Synonym

N,N',N''-((2S,2'S,2''S)-(((1S,1'S,1''S)-(1,3,5,2,4,6-Trioxatriborinane-2,4,6-triyl)tris(3-methylbutane-1,1-diyl))tris(azanediyl))tris(1-oxo-3-phenylpropane-1,2-diyl))tris(pyrazine-2-carboxamide); N-[1-[[1-[4,6-bis[3-methyl-1-[[3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]-1,3,5,2,4,6-trioxatriborinan-2-yl]-3-methylbutyl]amino]-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide; Bortezomib (S,S-Isomer)

Keywords
Impurities
Metabolites.
Pharmaceutical Standards
Intermediates
Fine Chemicals
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Bortezomib Impurity 49 is a defined impurity associated with Bortezomib that may form during chemical synthesis or degradation over time. It has a slightly altered structure compared with the active drug and is routinely monitored and controlled in accordance with pharmaceutical quality standards to ensure product safety, stability, and consistent therapeutic effectiveness.